CARGO Therapeutics, Inc. Common StockCRGXNASDAQ
Loading
| Metric | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +12.08% | +23.25% | +11.73% | +16.71% | +11.05% |
| Weighted Average Shares Diluted Growth | +12.08% | +23.25% | +11.73% | +16.71% | +11.05% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +429.47% | +504.63% | +17.02% | -41.22% | -68.11% |
| Inventory Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +709.98% | +447.20% | -8.60% | -14.32% | -47.22% |
| Book Value per Share Growth | +0.00% | +698.11% | -20.47% | -35.15% | -50.92% |
| Debt Growth | +710.19% | +24.00% | +3.10% | +7.95% | -97.95% |
| R&D Expense Growth | +168.92% | +61.62% | +45.95% | +0.44% | -79.95% |
| SG&A Expenses Growth | +206.70% | +301.29% | +153.28% | +11.70% | -30.08% |